Does Mark Lynas’s “conversion” represent a turning point in the GM debate?

Keith Kloor | Bloomberg | 
Anyone who believes the combustible GM discourse has turned a corner would do well to remember similar pronouncements made about ...

Stem cell showdown: Small business vs. the FDA

Susan Berfield | Bloomberg | 
Celltex’s venture raises some of the most vexing, emotional issues in the business of medicine. Stem cells hold enormous promise, ...

Oldest man in world has “genetic edge”

Kanoko Matsuyama, Meg Tirrell | Bloomberg | 
Jiroemon Kimura, who became the world's oldest man on record last week, can thank a combination of luck early in ...

The benefits of DNA science should be shared across social and class lines

John Lauerman | Bloomberg | 
Sharing the benefits of DNA science across social and class lines is one of the next big challenges facing genome ...

Fumbled DNA tests mean peril for breast-cancer patients

Robert Langreth | Bloomberg | 
Debbie McCarron was prepared to get both of her breasts taken off if a blood test in December 2006 revealed ...

Is bug resistant GM corn losing its effectiveness?

Jack Kaskey | Bloomberg | 
There’s “mounting evidence” that Monsanto Co. (MON) corn that’s genetically modified to control insects is losing its effectiveness in the ...

Ancient human kin’s DNA code illuminates rise of brains

John Lauerman | Bloomberg | 
DNA analysis of an extinct human ancestor that lived 80,000 years ago has pinpointed fundamental genes tied to the brain’s ...

Stem cell therapy for Autism to be tested in first trial

Ryan Flinn | Bloomberg | 
Researchers are recruiting autistic children for a study that will test whether injecting stem cells banked from their umbilical cords ...

California gene-altered food campaigns draw $4.3 million

James Nash | Bloomberg | 
A campaign to make California the first state to require labeling of genetically modified foods has raised $2.3 million in ...

USDA seeks comment on nine biotech crops in bid to speed reviews

Jack Kaskey | Bloomberg | 
The U.S. Department of Agriculture is seeking public input on nine new genetically modified crops developed by companies such as ...

DNA mapping of Alzheimer’s patients gives deep dive view

Michelle Fay Cortez | Bloomberg | 
Over the past 18 months, 81-year-old Bill Bunnell has visited the doctor a half-dozen times to take memory tests, provide ...

France’s Le Foll to keep biotech-crops ban, Le Monde says

Rudy Ruitenberg | Bloomberg | 
French Agriculture Minister Stephane Le Foll wants to keep the country’s moratorium on existing genetically-modified crops, Le Monde said, citing ...

Uganda may allow genetically modified crops to boost production

Fred Ojambo | Bloomberg | 
Uganda is considering a law to allow genetically modified crops to boost production, according to an industry group supporting biotech ...

Stress blocks gene that guards brain against depression

Elizabeth Lopatto | Bloomberg | 
Chronic stress appears to block a gene that guards against brain atrophy associated with depression, according to a study in ...

Monsanto crop bans by courts would be reversed in bill

Jack Kaskey | Bloomberg | 
A House of Representatives committee voted to let farmers grow genetically modified crops developed by Monsanto Co. (MON) and its ...

Rare DNA mutations raise questions about theories of disease

Ryan Finn | Bloomberg | 
Rare DNA mutations are so plentiful in the human genome that they make it difficult to precisely identify the genetic ...

Google founder targets cure for Parkinson’s disease

Robert Langreth | Bloomberg | 
Sergey Brin, the 38-year-old co- founder of Google Inc. (GOOG), is making strides in his quest to find a cure ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists